On 28 April 2025, Anja Lehmann, doctoral student co-supervised by us and Dr. Christoph Hethey, will defend her thesis on “Physiologically-based pharmacokinetic modeling of pyrrolizidine alkaloids and their cytochrome P450 3A4-mediated interaction”. She did her thesis at “Bundesinstitut für Risikobewertung (BfR)” and is PharMetrX Training+ student. Good luck Anja!